Literature DB >> 26404714

Resolving the neural circuits of anxiety.

Gwendolyn G Calhoon1, Kay M Tye1.   

Abstract

Although anxiety disorders represent a major societal problem demanding new therapeutic targets, these efforts have languished in the absence of a mechanistic understanding of this subjective emotional state. While it is impossible to know with certainty the subjective experience of a rodent, rodent models hold promise in dissecting well-conserved limbic circuits. The application of modern approaches in neuroscience has already begun to unmask the neural circuit intricacies underlying anxiety by allowing direct examination of hypotheses drawn from existing psychological concepts. This information points toward an updated conceptual model for what neural circuit perturbations could give rise to pathological anxiety and thereby provides a roadmap for future therapeutic development.

Entities:  

Mesh:

Year:  2015        PMID: 26404714     DOI: 10.1038/nn.4101

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  140 in total

1.  Amygdala neurons differentially encode motivation and reinforcement.

Authors:  Kay M Tye; Patricia H Janak
Journal:  J Neurosci       Date:  2007-04-11       Impact factor: 6.167

2.  Switching on and off fear by distinct neuronal circuits.

Authors:  Cyril Herry; Stephane Ciocchi; Verena Senn; Lynda Demmou; Christian Müller; Andreas Lüthi
Journal:  Nature       Date:  2008-07-09       Impact factor: 49.962

Review 3.  Cortical pathways to the mammalian amygdala.

Authors:  A J McDonald
Journal:  Prog Neurobiol       Date:  1998-06       Impact factor: 11.685

4.  Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder.

Authors:  Amit Etkin; Katherine E Prater; Alan F Schatzberg; Vinod Menon; Michael D Greicius
Journal:  Arch Gen Psychiatry       Date:  2009-12

5.  Passive and active avoidance behavior in the light-dark box test.

Authors:  C Ambrogi Lorenzini; C Bucherelli; A Giachetti
Journal:  Physiol Behav       Date:  1984-04

6.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

7.  The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress.

Authors:  Brook Henry; Wylie Vale; Athina Markou
Journal:  J Neurosci       Date:  2006-09-06       Impact factor: 6.167

8.  Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis.

Authors:  W E Cullinan; J P Herman; S J Watson
Journal:  J Comp Neurol       Date:  1993-06-01       Impact factor: 3.215

Review 9.  Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.

Authors:  Basil G Bereza; Márcio Machado; Thomas R Einarson
Journal:  Clin Ther       Date:  2009-06       Impact factor: 3.393

Review 10.  A framework for studying emotions across species.

Authors:  David J Anderson; Ralph Adolphs
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

View more
  192 in total

Review 1.  Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety.

Authors:  Xia Chen; Joop van Gerven; Adam Cohen; Gabriel Jacobs
Journal:  Acta Pharmacol Sin       Date:  2018-12-05       Impact factor: 6.150

Review 2.  Stress and the brain: individual variability and the inverted-U.

Authors:  Robert M Sapolsky
Journal:  Nat Neurosci       Date:  2015-10       Impact factor: 24.884

Review 3.  Architectural Representation of Valence in the Limbic System.

Authors:  Praneeth Namburi; Ream Al-Hasani; Gwendolyn G Calhoon; Michael R Bruchas; Kay M Tye
Journal:  Neuropsychopharmacology       Date:  2015-12-09       Impact factor: 7.853

4.  Animal models of OCD-relevant processes: an RDoC perspective.

Authors:  Christopher Pittenger; Helen Pushkarskaya; Patricia Gruner
Journal:  J Obsessive Compuls Relat Disord       Date:  2019-04-03       Impact factor: 1.677

Review 5.  Modeling anxiety in healthy humans: a key intermediate bridge between basic and clinical sciences.

Authors:  Christian Grillon; Oliver J Robinson; Brian Cornwell; Monique Ernst
Journal:  Neuropsychopharmacology       Date:  2019-06-21       Impact factor: 7.853

6.  Anxiety Cells in a Hippocampal-Hypothalamic Circuit.

Authors:  Jessica C Jimenez; Katy Su; Alexander R Goldberg; Victor M Luna; Jeremy S Biane; Gokhan Ordek; Pengcheng Zhou; Samantha K Ong; Matthew A Wright; Larry Zweifel; Liam Paninski; René Hen; Mazen A Kheirbek
Journal:  Neuron       Date:  2018-01-31       Impact factor: 17.173

7.  Hunger-Driven Motivational State Competition.

Authors:  C Joseph Burnett; Chia Li; Emily Webber; Eva Tsaousidou; Stephen Y Xue; Jens C Brüning; Michael J Krashes
Journal:  Neuron       Date:  2016-09-29       Impact factor: 17.173

Review 8.  An Emerging Circuit Pharmacology of GABAA Receptors.

Authors:  Elif Engin; Rebecca S Benham; Uwe Rudolph
Journal:  Trends Pharmacol Sci       Date:  2018-06-11       Impact factor: 14.819

9.  Anatomically Defined and Functionally Distinct Dorsal Raphe Serotonin Sub-systems.

Authors:  Jing Ren; Drew Friedmann; Jing Xiong; Cindy D Liu; Brielle R Ferguson; Tanya Weerakkody; Katherine E DeLoach; Chen Ran; Albert Pun; Yanwen Sun; Brandon Weissbourd; Rachael L Neve; John Huguenard; Mark A Horowitz; Liqun Luo
Journal:  Cell       Date:  2018-08-23       Impact factor: 41.582

10.  Functional and neurochemical interactions within the amygdala-medial prefrontal cortex circuit and their relevance to emotional processing.

Authors:  Stefano Delli Pizzi; Piero Chiacchiaretta; Dante Mantini; Giovanna Bubbico; Antonio Ferretti; Richard A Edden; Camillo Di Giulio; Marco Onofrj; Laura Bonanni
Journal:  Brain Struct Funct       Date:  2016-08-26       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.